High demand for weight loss drugs like Ozempic and Wegovy is impacting employer health care costs-but it can be critical for retaining talent
Briefly

The average health care cost per employee increased 4.5% this year to $16,501, reflecting growing spending tied to the demand for weight loss drugs like Ozempic and Wegovy.
Around 44% of large companies provide coverage for obesity drugs, a rise from 41% last year, indicating a trend towards expanding health benefits to attract talent.
Tracy Watts emphasizes, 'Expanding health benefits can play a crucial role in attracting and retaining talent,' underscoring the importance of quality care access amid rising costs.
As obesity affects about 40% of U.S. adults, the sustained demand for GLP-1 drugs like Ozempic suggests ongoing challenges for employers managing health care expenses.
Read at Fortune
[
|
]